PL377476A1 - Oznaczanie CVD - Google Patents
Oznaczanie CVDInfo
- Publication number
- PL377476A1 PL377476A1 PL377476A PL37747603A PL377476A1 PL 377476 A1 PL377476 A1 PL 377476A1 PL 377476 A PL377476 A PL 377476A PL 37747603 A PL37747603 A PL 37747603A PL 377476 A1 PL377476 A1 PL 377476A1
- Authority
- PL
- Poland
- Prior art keywords
- calprotectin
- antibody
- assay
- cvd
- body fluid
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54346—Nanoparticles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/02—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4727—Calcium binding proteins, e.g. calmodulin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Nanotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Gyroscopes (AREA)
- Optical Head (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Mechanical Treatment Of Semiconductor (AREA)
- Devices For Conveying Motion By Means Of Endless Flexible Members (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0229747.1A GB0229747D0 (en) | 2002-12-20 | 2002-12-20 | Assay |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL377476A1 true PL377476A1 (pl) | 2006-02-06 |
| PL216385B1 PL216385B1 (pl) | 2014-03-31 |
Family
ID=9950111
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL377476A PL216385B1 (pl) | 2002-12-20 | 2003-12-22 | Sposób testowania do wykrywania możliwości wystąpienia lub skłonności do choroby niedokrwiennej serca lub udaru |
| PL394295A PL394295A1 (pl) | 2002-12-20 | 2003-12-22 | Sposób oznaczania kalprotektyny, zestaw do stosowania w tym sposobie, zautomatyzowany aparat oraz sposób diagnozowania choroby |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL394295A PL394295A1 (pl) | 2002-12-20 | 2003-12-22 | Sposób oznaczania kalprotektyny, zestaw do stosowania w tym sposobie, zautomatyzowany aparat oraz sposób diagnozowania choroby |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US10101325B2 (pl) |
| EP (2) | EP1573335B1 (pl) |
| JP (2) | JP4653492B2 (pl) |
| CN (3) | CN101893635B (pl) |
| AT (2) | ATE427498T1 (pl) |
| AU (1) | AU2003295142A1 (pl) |
| CA (2) | CA2729365C (pl) |
| DE (2) | DE60327007D1 (pl) |
| DK (2) | DK1573335T3 (pl) |
| ES (2) | ES2297250T3 (pl) |
| GB (1) | GB0229747D0 (pl) |
| NO (1) | NO20052161L (pl) |
| PL (2) | PL216385B1 (pl) |
| PT (1) | PT1573335E (pl) |
| SI (1) | SI1573335T1 (pl) |
| WO (1) | WO2004057341A2 (pl) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0229747D0 (en) * | 2002-12-20 | 2003-01-29 | Axis Shield Asa | Assay |
| US7659087B2 (en) | 2004-07-23 | 2010-02-09 | Aspenbio Pharma, Inc. | Methods and devices for diagnosis of appendicitis |
| CA2574991C (en) | 2004-07-23 | 2015-03-24 | Aspenbio Pharma, Inc. | Methods for diagnosis of appendicitis |
| EP1862805A1 (en) * | 2006-06-01 | 2007-12-05 | University of Zürich | The use of mrp 8/14 levels for discrimination of individuals at risk of acute coronary syndromes |
| WO2010101950A1 (en) * | 2009-03-02 | 2010-09-10 | Catholic Healthcare West | Diagnostic devices and methods of use |
| PT2427482T (pt) * | 2009-05-07 | 2020-03-04 | Chreto Aps | Método para purificação de polipéptidos alvo |
| US9574977B2 (en) * | 2013-02-26 | 2017-02-21 | Innova Prep | Liquid to liquid biological particle concentrator with disposable fluid path |
| EP2511704A1 (en) | 2011-04-13 | 2012-10-17 | Immundiagnostik AG | Assay method for intrinsic acute kidney injury |
| NO20110895A1 (no) * | 2011-06-21 | 2012-12-24 | Magne Fagerhol | Kompetitive S100A9 immunoanalyser |
| ES2402457B2 (es) * | 2011-10-19 | 2014-01-20 | Universidade De Vigo | Procedimiento para el diagnóstico de derrame pleural maligno mediante la determinación de la concentración de calprotectina en líquido pleural. |
| US9594999B2 (en) | 2012-04-03 | 2017-03-14 | X-Card Holdings, Llc | Information carrying card comprising crosslinked polymer composition, and method of making the same |
| US9122968B2 (en) | 2012-04-03 | 2015-09-01 | X-Card Holdings, Llc | Information carrying card comprising a cross-linked polymer composition, and method of making the same |
| SG11201501684UA (en) * | 2012-09-12 | 2015-04-29 | Berg Llc | Use of markers in the identification of cardiotoxic agents |
| WO2014149926A1 (en) | 2013-03-15 | 2014-09-25 | X-Card Holdings, Llc | Methods of making a core layer for an information carrying card, and resulting products |
| ES2948232T3 (es) * | 2017-02-07 | 2023-09-06 | Lyfstone B V | Biomarcadores para diagnosticar el riesgo de revisión del implante relacionado con el implante debido a un aflojamiento aséptico |
| EP3385712A1 (en) | 2017-04-03 | 2018-10-10 | Gentian AS | Improved calprotectin assay |
| CN111094978B (zh) * | 2017-05-09 | 2024-05-28 | 免疫诊断股份公司 | 免疫比浊法测定钙结合蛋白s100家族成员的方法 |
| CN108196066A (zh) * | 2018-01-22 | 2018-06-22 | 安徽伊普诺康生物技术股份有限公司 | 一种测定钙防卫蛋白的试剂盒及其制备使用方法 |
| EP3762871B1 (en) | 2018-03-07 | 2024-08-07 | X-Card Holdings, LLC | Metal card |
| WO2021229016A1 (en) * | 2020-05-13 | 2021-11-18 | Nordic Bioscience A/S | Calprotectin assay |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4287202A (en) | 1978-05-26 | 1981-09-01 | Horrobin David F | Treatment and/or prophylaxis of spasms of coronary arteries |
| JPS55162059A (en) * | 1979-06-05 | 1980-12-17 | Mochida Pharmaceut Co Ltd | Measuring method for antigen, antibody or their complex and measurement reagent kit |
| US4401765A (en) * | 1981-09-01 | 1983-08-30 | E. I. Du Pont De Nemours And Company | Covalently bonded high refractive index particle reagents and their use in light scattering immunoassays |
| US4480042A (en) * | 1981-10-28 | 1984-10-30 | E. I. Du Pont De Nemours And Company | Covalently bonded high refractive index particle reagents and their use in light scattering immunoassays |
| GB8318754D0 (en) * | 1983-07-11 | 1983-08-10 | Fagerhol M K F | Human proteins anti-sera test kits |
| JPS60139621A (ja) | 1983-12-27 | 1985-07-24 | Grelan Pharmaceut Co Ltd | 抗血栓剤 |
| JPS625970A (ja) | 1985-03-15 | 1987-01-12 | Terumo Corp | ピラジン誘導体およびこれを含有する血小板凝集抑制剤 |
| EP0310361A3 (en) * | 1987-09-30 | 1989-05-24 | Beckman Instruments, Inc. | Tridentate conjugate and method of use thereof |
| GB2218100A (en) * | 1988-03-02 | 1989-11-08 | Erling Sundrehagen | Conjugates for the detection and/or quantification of antigenic substances in body fluids |
| DE69027560T2 (de) * | 1989-08-23 | 1997-01-09 | Canon K.K., Tokio/Tokyo | Methode zur Messung eines immunologisch aktiven Materials und Vorrichtung, die dazu geeignet ist |
| US5455160A (en) * | 1993-05-27 | 1995-10-03 | Fagerhol; Magne K. | Diagnostic test and kit for disease or disorders in the digestive system |
| US5776348A (en) | 1995-02-07 | 1998-07-07 | Massachusetts Institute Of Technology | Mineral precipitation system and method for inhibiting mineral precipitate formation |
| CA2268926A1 (en) | 1996-11-01 | 1998-05-14 | Nycomed Pharma A/S | Process for the extraction of proteins |
| ES2374621T3 (es) | 1997-04-02 | 2012-02-20 | The Brigham And Women's Hospital, Inc. | Medios para evaluar el perfil de riesgo de un individuo de sufrir una enfermedad ateroesclerótica. |
| GB9816088D0 (en) * | 1998-07-23 | 1998-09-23 | Axis Biochemicals Asa | System |
| AU5436499A (en) * | 1998-08-20 | 2000-03-14 | Axis Biochemicals Asa | Assay method for cardiovascular disease |
| WO2001002853A2 (en) * | 1999-07-05 | 2001-01-11 | K.U. Leuven Research & Development | DETECTION OF VON-WILLEBRANDFACTOR (vWF) ACTIVITY |
| AU782386C (en) | 1999-08-31 | 2006-08-10 | Brigham And Women's Hospital | Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases |
| FR2800636A1 (fr) * | 1999-11-05 | 2001-05-11 | Bio Merieux | Particules composites, conjugues derives, leur procede de preparation et utilisations |
| US7011952B2 (en) * | 2000-02-22 | 2006-03-14 | University Of Iowa Research Foundation | Diagnostics and therapeutics for macular degeneration-related disorders |
| US20030059461A1 (en) | 2000-06-06 | 2003-03-27 | Sibtech, Inc. | Molecular delivery vehicle for delivery of selected compounds to targets |
| WO2002018953A1 (fr) * | 2000-08-29 | 2002-03-07 | Kyowa Medex Co.,Ltd | Reactifs et methode d'immunoessai d'agglutination fortement reproductible |
| WO2002089657A2 (en) * | 2001-05-04 | 2002-11-14 | Biosite, Inc. | Diagnostic markers of acute coronary syndromes and methods of use thereof |
| JP2002318233A (ja) * | 2001-04-19 | 2002-10-31 | Shino Test Corp | 測定対象物質の比濁法測定試薬及び測定対象物質の比濁法測定方法 |
| GB0229747D0 (en) * | 2002-12-20 | 2003-01-29 | Axis Shield Asa | Assay |
| FR2872579B1 (fr) * | 2004-06-30 | 2006-11-24 | Pasteur Institut | Detection de la tuberculose et de l'infection par mycobacterium tuberculosis a l'aide de hbha |
| US7623910B2 (en) * | 2006-03-10 | 2009-11-24 | University Of Rochester | ECG-based differentiation of LQT1 and LQT2 mutation |
-
2002
- 2002-12-20 GB GBGB0229747.1A patent/GB0229747D0/en not_active Ceased
-
2003
- 2003-12-22 DK DK03786143T patent/DK1573335T3/da active
- 2003-12-22 EP EP03786143A patent/EP1573335B1/en not_active Expired - Lifetime
- 2003-12-22 AT AT06021890T patent/ATE427498T1/de active
- 2003-12-22 PT PT03786143T patent/PT1573335E/pt unknown
- 2003-12-22 DE DE60327007T patent/DE60327007D1/de not_active Expired - Lifetime
- 2003-12-22 AU AU2003295142A patent/AU2003295142A1/en not_active Abandoned
- 2003-12-22 CN CN201010167371.0A patent/CN101893635B/zh not_active Expired - Fee Related
- 2003-12-22 DK DK06021890T patent/DK1739430T3/da active
- 2003-12-22 SI SI200331123T patent/SI1573335T1/sl unknown
- 2003-12-22 PL PL377476A patent/PL216385B1/pl not_active IP Right Cessation
- 2003-12-22 ES ES03786143T patent/ES2297250T3/es not_active Expired - Lifetime
- 2003-12-22 ES ES06021890T patent/ES2323475T3/es not_active Expired - Lifetime
- 2003-12-22 CN CN2012100207169A patent/CN102608326A/zh active Pending
- 2003-12-22 PL PL394295A patent/PL394295A1/pl not_active IP Right Cessation
- 2003-12-22 EP EP06021890A patent/EP1739430B1/en not_active Expired - Lifetime
- 2003-12-22 US US10/539,797 patent/US10101325B2/en active Active
- 2003-12-22 WO PCT/GB2003/005607 patent/WO2004057341A2/en active IP Right Grant
- 2003-12-22 JP JP2004561672A patent/JP4653492B2/ja not_active Expired - Fee Related
- 2003-12-22 CN CN2003801069127A patent/CN1729398B/zh not_active Expired - Fee Related
- 2003-12-22 CA CA2729365A patent/CA2729365C/en not_active Expired - Lifetime
- 2003-12-22 DE DE60317931T patent/DE60317931T2/de not_active Expired - Lifetime
- 2003-12-22 CA CA002504876A patent/CA2504876A1/en not_active Abandoned
- 2003-12-22 AT AT03786143T patent/ATE380345T1/de active
-
2005
- 2005-05-03 NO NO20052161A patent/NO20052161L/no not_active Application Discontinuation
-
2009
- 2009-09-24 JP JP2009219158A patent/JP5744385B2/ja not_active Expired - Fee Related
-
2011
- 2011-06-28 US US13/170,387 patent/US20110318847A1/en not_active Abandoned
-
2018
- 2018-10-15 US US16/159,786 patent/US20190049439A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20052161D0 (no) | Analysemetode for hjerte-karsykdom | |
| WO2007011936A3 (en) | Lateral flow assay and device using magnetic particles | |
| EP2538218A3 (en) | Biochemical markers for CVD risk assessment | |
| ATE358274T1 (de) | Diagnostisches testverfahren | |
| MY162697A (en) | Methods, devices and kits for detecting or monitoring acute kidney injury | |
| WO2010038974A3 (ko) | 이뮤노글로블린 에이 신증과 티지비엠 신증의 진단용 조성물 및 키트 | |
| ATE410684T1 (de) | Molekular-modifikations-assays | |
| JP2012509477A5 (pl) | ||
| WO2006047591A3 (en) | Rapid microfluidic assay for analyte interactions | |
| MX2009003572A (es) | Metodos para reducir interferencia optica en un dispositivo de fluido. | |
| WO2006119155A3 (en) | Diagnostic serum antibody profiling | |
| WO2005073405A3 (en) | Catalytic polynucleotide and its use for determination of analytes | |
| Salama et al. | Chemiluminescent optical fiber immunosensor for detection of autoantibodies to ovarian and breast cancer-associated antigens | |
| ATE467128T1 (de) | Kolloidale metallkonjugate | |
| IláKim | Detection and quantification of the Bcr/Abl chimeric protein on biochips using LDI-TOF MS | |
| CN103575875A (zh) | 一种新的功能化金纳米棒免疫探针及金纳米棒生物芯片的制备方法及应用 | |
| JP2009544971A5 (pl) | ||
| WO2008067008A3 (en) | A method for the quantitative evaluation of sex hormones in a serum sample | |
| WO2006119262A3 (en) | Detection of carbohydrate biomarkers | |
| DE60332479D1 (de) | Holo-transcobalamin bindungspartner und ihre verwendung in cobalamintest | |
| Liu et al. | Capacitive immunosensing of polycyclic aromatic hydrocarbon and protein conjugates | |
| WO2008036470A3 (en) | A method for screening of infectious agents in blood | |
| WO2006044888A3 (en) | Reagents for urine-based immunological assays | |
| Li et al. | Flow sandwich immunoassay for specific anti-OVA IgG antibody by use of surface plasmon resonance sensor | |
| ATE520985T1 (de) | Verfahren zur bestimmung von antigen und antikörper gegen das antigen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| VDSO | Invalidation of derivated patent or utility model |
Ref document number: 394295 Country of ref document: PL Kind code of ref document: A1 |
|
| RECP | Rectifications of patent specification |